Resources

Risk of type 2 diabetes heightened in elderly women with increase in statin dose.

Epalrestat, an AKR1B1 inhibitor for diabetic patients inhibits progression of BLBC

Which one of the following is an advantage of a glucagon-like peptide-1 (GLP-1) receptor agonist over mealtime insulin? A. Less hypoglycemia B. Fewer injections C. Less weight gain D. All of the above Follow the link to see the correct answer!

For your patients using metformin, do you assess their Vitamin B12 levels? Follow the link to share your response.

I don’t know how many times I have the opportunity to teach patients and health care providers that it’s not all about food. I was recently reminded of that when I overheard a dietitian, a CDE, go over a 4-week CGM report with a patient, male, 53 years of age, type 2 diabetes, non-obese, actually not even overweight.

In part 2 of this Exclusive Interview, Michael Hill explains what the hybrid closed-loop system can and can't do as well as some of the benefits.

In this week's Homerun Slides, successful - and unsuccessful - medications and clinical trials.

Transcriptional regulation of gluconeogenesis: The gradual shift from the fed-to-fasted state is followed closely by hormonal regulation of genes encoding PEPCK, fructose-1,6-bisphosphatase, and the glucose-6-phosphatase catalytic subunit. The transcriptional regulation of these genes remains a developing research area and its many emerging nuances cannot be completely covered here.

The reason may be simpler than first thought.

Does an ounce of prevention beat a pound of cure?